SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.
Contract Category
11 federal contract opportunities classified as Rare Diseases.
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The THRIVE program seeks innovative solutions for treating hereditary rare diseases through in vivo precision genetic medicines. Amendments to the solicitation include updates to proposal requirements and templates. Interested parties must submit solution summaries by October 31, 2025, and can find more information on …
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The THRIVE program by ARPA-H seeks innovative solutions for treating hereditary rare diseases through in vivo precision genetic medicines. Proposals are due by October 31, 2025, with a virtual presentation scheduled from January 5 to January 16, 2026. Interested parties should review the attached documents for detailed…
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The THRIVE program by ARPA-H seeks innovative solutions for treating hereditary rare diseases through in vivo precision genetic medicines. Proposals are due by October 31, 2025, with a virtual presentation scheduled between January 5 and January 16, 2026. Interested parties should review the attached documents for deta…
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The THRIVE program by ARPA-H seeks innovative solutions for treating hereditary rare diseases through in vivo precision genetic medicines. Proposals are due by October 31, 2025, with virtual presentations scheduled from January 5 to January 16, 2026. Interested parties should review the attached documents for detailed …
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The THRIVE program seeks innovative solutions for treating hereditary rare diseases through in vivo precision genetic medicines. Proposals are due by October 31, 2025, with a virtual PowerPoint presentation required for evaluation. Interested parties should review the attached documents for detailed requirements and ch…
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The THRIVE program by ARPA-H seeks innovative solutions for treating hereditary rare diseases through in vivo precision genetic medicines. Amendments clarify team organization requirements and encourage cost-sharing. Solution summaries are due by October 31, 2025. Interested parties should review the attached documents…
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The THRIVE program by ARPA-H seeks innovative solutions for treating hereditary rare diseases through in vivo precision genetic medicines. Recent amendments encourage cost-sharing and clarify regulatory facilitation. Interested parties must submit solution summaries by October 31, 2025. For more details, visit the ARPA…
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The THRIVE program by ARPA-H seeks innovative solutions for treating hereditary rare diseases through in vivo precision genetic medicines. Interested parties should review the attached solicitation and submit solution summaries by October 31, 2025. For more details, visit the ARPA-H website.
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The National Institutes of Health is extending the registration deadline for lightning talks and sidebars related to the THRIVE program, focusing on treating hereditary rare diseases with in vivo precision genetic medicines. The new registration deadline is October 2, 2025, with additional slots available on October 3,…
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The THRIVE program by ARPA-H seeks innovative solutions for treating hereditary rare diseases through in vivo precision genetic medicines. Interested parties should submit solution summaries by October 31, 2025. For more details, visit the ARPA-H website.
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The THRIVE program by ARPA-H seeks innovative solutions for treating hereditary rare diseases through in vivo precision genetic medicines. Interested parties should submit solution summaries by October 31, 2025. For more details, visit the ARPA-H website.
MD
Common questions about finding and winning Rare Diseases government contracts.